|

HDM1002 200 mg Clinical Trials

2 actively recruiting trials

No change since May 2026

Also known as: HDM1002

Pipeline

Phase 3: 2

Top Sponsors

  • Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.2

Indications

Other2 trials

A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
Phase 3
Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.